Ozempic label now notes potential side effect of intestinal blockage

The U.S. Food and Drug Administration (FDA) updated the label for Ozempic, a type 2 diabetes drug that is often used for weight loss, to now note the potential side effect of intestinal blockage. In a series of labeling changes for Ozempic, the FDA said the medication will now... #press

https://thehill.com/policy/healthcare/4226499-ozempic-label-now-notes-potential-side-effect-of-intestinal-blockage/?utm_source=press.coop

?w=900